Published in Forensic Sci Int Genet on November 23, 2010
Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns. PLoS Genet (2012) 1.68
Admixture and gene flow from Russia in the recovering Northern European brown bear (Ursus arctos). PLoS One (2014) 0.99
Utility of GenBank and the Barcode of Life Data Systems (BOLD) for the identification of forensically important Diptera from Belgium and France. Zookeys (2013) 0.97
Where is the game? Wild meat products authentication in South Africa: a case study. Investig Genet (2013) 0.87
Feather barbs as a good source of mtDNA for bird species identification in forensic wildlife investigations. Investig Genet (2011) 0.85
Evidence of rapid change in genetic structure and diversity during range expansion in a recovering large terrestrial carnivore. Proc Biol Sci (2015) 0.83
Bite through the tent. Int J Legal Med (2012) 0.80
An assessment of scientific and technical aspects of closed investigations of canine forensics DNA--case series from the University of California, Davis, USA. Croat Med J (2011) 0.79
Evaluation of a 13-loci STR multiplex system for Cannabis sativa genetic identification. Int J Legal Med (2015) 0.77
U.S. initiatives to strengthen forensic science & international standards in forensic DNA. Forensic Sci Int Genet (2015) 0.75
Polymorphic DNA microsatellite markers for forensic individual identification and parentage analyses of seven threatened species of parrots (family Psittacidae). PeerJ (2016) 0.75
Reviewing population studies for forensic purposes: Dog mitochondrial DNA. Zookeys (2013) 0.75
Forensic genetics and genomics: Much more than just a human affair. PLoS Genet (2017) 0.75
Helminths of brown bears (Ursus arctos) in the Kola Peninsula. Parasitol Res (2017) 0.75
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med (2001) 3.32
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures. Forensic Sci Int (2006) 3.20
Evaluation of Y-chromosomal STRs: a multicenter study. Int J Legal Med (1997) 3.19
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28
HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology (1991) 2.24
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Forensic Sci Int (2006) 2.22
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Int J Legal Med (2006) 2.00
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol (1997) 1.97
Chromosome Y microsatellites: population genetic and evolutionary aspects. Int J Legal Med (1997) 1.89
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol (1997) 1.78
Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain (2009) 1.69
Online reference database of European Y-chromosomal short tandem repeat (STR) haplotypes. Forensic Sci Int (2001) 1.67
High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy (2006) 1.66
Consistent treatment of length variants in the human mtDNA control region: a reappraisal. Int J Legal Med (2007) 1.65
Nucleotide sequence of a bovine protamine cDNA. Biol Chem Hoppe Seyler (1987) 1.61
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Rare failures in the amelogenin sex test. Int J Legal Med (2002) 1.57
A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol (1998) 1.56
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53
Association of G-protein-coupled receptor 154 with asthma and total IgE in a population of the Caribbean coast of Colombia. Clin Exp Allergy (2009) 1.49
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49
Paternity Testing Commission of the International Society of Forensic Genetics. Recommendations on genetic investigations in paternity cases. Int J Legal Med (2003) 1.46
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43
Considerations by the European DNA profiling (EDNAP) group on the working practices, nomenclature and interpretation of mitochondrial DNA profiles. Forensic Sci Int (2001) 1.43
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol (2001) 1.42
No primary association between LMP2 polymorphisms and extraspinal manifestations in spondyloarthropathies. Ann Rheum Dis (1997) 1.41
Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol (1980) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[The HL-A-system in paternity testing (author's transl)]. Z Rechtsmed (1974) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Defective macrophage function in a patient with common variable immunodeficiency. N Engl J Med (1982) 1.38
DNA commission of the international society for forensic genetics: guidelines for mitochondrial DNA typing. Forensic Sci Int (2000) 1.37
A dreadful dilemma: individual versus global health perspectives. Pharos Alpha Omega Alpha Honor Med Soc (1991) 1.37
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol (1988) 1.37
HLA--Dw4 and rheumatoid arthritis. Tissue Antigens (1979) 1.36
European Network of Forensic Science Institutes (ENFSI): Evaluation of new commercial STR multiplexes that include the European Standard Set (ESS) of markers. Forensic Sci Int Genet (2012) 1.35
Transepithelial prion transport by M cells. Nat Med (2001) 1.35
A new method for the evaluation of matches in non-recombining genomes: application to Y-chromosomal short tandem repeat (STR) haplotypes in European males. Forensic Sci Int (2000) 1.35
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
HLA antigens in inflammatory bowel disease. Gastroenterology (1982) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Molecular biology of esophageal cancer. Onkologie (2004) 1.28
DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med (2001) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
DNA Commission of the International Society for Forensic Genetics (ISFG): recommendations regarding the role of forensic genetics for disaster victim identification (DVI). Forensic Sci Int Genet (2006) 1.28
[Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?]. Zentralbl Chir (2003) 1.26
Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. Hum Mol Genet (2000) 1.23
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
Analysis of artificially degraded DNA using STRs and SNPs--results of a collaborative European (EDNAP) exercise. Forensic Sci Int (2005) 1.21
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J Biol Chem (1997) 1.20
HLA-DR and Hashimoto's thyroiditis. Tissue Antigens (1980) 1.20
Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol (2002) 1.20
A new "miniSTR-multiplex" displaying reduced amplicon lengths for the analysis of degraded DNA. Int J Legal Med (2005) 1.19
Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine (2000) 1.19
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
DNA Commission of the International Society for Forensic Genetics: guidelines for mitochondrial DNA typing. Int J Legal Med (2000) 1.18
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene (2001) 1.17
Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer (2000) 1.16
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res (2001) 1.16
Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology (2001) 1.14
The germline repertoire of T-cell receptor beta chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis. Immunogenetics (1990) 1.13
Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion (1996) 1.13
Epidemiology of osteoporosis. II. Incidence of hip fractures in mental institutions. J Bone Joint Surg Am (1968) 1.12
Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum (1998) 1.12
xylP promoter-based expression system and its use for antisense downregulation of the Penicillium chrysogenum nitrogen regulator NRE. Appl Environ Microbiol (2000) 1.11
DNA commission of the International Society of Forensic Genetics: Recommendations on the evaluation of STR typing results that may include drop-out and/or drop-in using probabilistic methods. Forensic Sci Int Genet (2012) 1.11